Astrana Health, Inc. (ASTH) stock
ASTHNasdaqServices-Management Consulting ServicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 12/307% below fair value
$31.80+0.03 (+0.09%)
Close on Nov 13, 2026Market cap $1.77BP/E 29.7Yield –
Astrana Health r&d expenses
Research and development expenses are spending on new products and technology.
No r&d expenses figures for Astrana Health
Astrana Health has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?